News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
309,216 Results
Type
Article (11167)
Company Profile (61)
Press Release (297987)
Multimedia
Podcasts (10)
Webinars (5)
Section
Business (99970)
Career Advice (688)
Deals (17864)
Drug Delivery (15)
Drug Development (30978)
Employer Resources (40)
FDA (6766)
Job Trends (6384)
News (156229)
Policy (11116)
Tag
Academia (807)
Accelerated approval (11)
Adcomms (4)
Allergies (102)
Alliances (20801)
ALS (63)
Alzheimer's disease (571)
Antibody-drug conjugate (ADC) (86)
Approvals (7025)
Artificial intelligence (185)
Autoimmune disease (51)
Automation (15)
Bankruptcy (115)
Best Places to Work (5222)
BIOSECURE Act (2)
Biosimilars (62)
Biotechnology (57)
Bladder cancer (74)
Brain cancer (19)
Breast cancer (271)
Cancer (1846)
Cardiovascular disease (114)
Career advice (594)
Career pathing (11)
CAR-T (101)
CDC (4)
Cell therapy (268)
Cervical cancer (9)
Clinical research (26902)
Collaboration (629)
Compensation (405)
Complete response letters (11)
COVID-19 (833)
CRISPR (25)
C-suite (406)
Cystic fibrosis (55)
Data (2555)
Denatured (2)
Depression (37)
Diabetes (142)
Diagnostics (3011)
Digital health (8)
Diversity, equity & inclusion (18)
Drug discovery (114)
Drug pricing (23)
Drug shortages (6)
Duchenne muscular dystrophy (72)
Earnings (46800)
Editorial (10)
Employer branding (6)
Employer resources (42)
Events (50079)
Executive appointments (563)
FDA (8015)
Fibrodysplasia Ossificans Progressiva (3)
Friedreich's ataxia (2)
Frontotemporal dementia (12)
Funding (566)
Gene editing (53)
Generative AI (17)
Gene therapy (164)
GLP-1 (245)
Government (1022)
Grass and pollen (4)
Guidances (231)
Healthcare (6891)
HIV (21)
Huntington's disease (15)
IgA nephropathy (36)
Immunology and inflammation (71)
Immuno-oncology (11)
Indications (43)
Infectious disease (899)
Inflammatory bowel disease (78)
Inflation Reduction Act (3)
Influenza (29)
Intellectual property (52)
Interviews (86)
IPO (9053)
IRA (6)
Job creations (1404)
Job search strategy (536)
Kidney cancer (11)
Labor market (13)
Layoffs (140)
Leadership (8)
Legal (2934)
Liver cancer (31)
Longevity (6)
Lung cancer (203)
Lymphoma (165)
Machine learning (15)
Management (14)
Manufacturing (195)
MASH (58)
Medical device (4682)
Medtech (4691)
Mergers & acquisitions (9332)
Metabolic disorders (342)
Multiple sclerosis (58)
NASH (8)
Neurodegenerative disease (114)
Neuropsychiatric disorders (19)
Neuroscience (1029)
NextGen: Class of 2025 (2237)
Non-profit (1182)
Now hiring (16)
Obesity (141)
Opinion (68)
Ovarian cancer (57)
Pain (47)
Pancreatic cancer (63)
Parkinson's disease (103)
Partnered (15)
Patents (87)
Patient recruitment (140)
Peanut (55)
People (32169)
Pharmaceutical (13)
Pharmacy benefit managers (3)
Phase I (7755)
Phase II (11120)
Phase III (9907)
Pipeline (2233)
Policy (42)
Postmarket research (1174)
Preclinical (3338)
Press Release (69)
Prostate cancer (102)
Psychedelics (10)
Radiopharmaceuticals (138)
Rare diseases (280)
Real estate (2343)
Recruiting (10)
Regulatory (8585)
Reports (20)
Research institute (846)
Resumes & cover letters (91)
Rett syndrome (22)
RNA editing (6)
RSV (11)
Schizophrenia (71)
Series A (102)
Series B (74)
Service/supplier (2)
Sickle cell disease (33)
Special edition (1)
Spinal muscular atrophy (61)
Sponsored (11)
Startups (1535)
State (1)
Stomach cancer (3)
Supply chain (28)
Tariffs (11)
The Weekly (8)
Vaccines (239)
Venture capital (19)
Weight loss (70)
Women's health (12)
Worklife (3)
Date
Today (50)
Last 7 days (253)
Last 30 days (1041)
Last 365 days (13888)
2025 (13683)
2024 (16335)
2023 (19053)
2022 (25523)
2021 (27303)
2020 (24467)
2019 (18269)
2018 (13841)
2017 (13862)
2016 (12854)
2015 (16263)
2014 (12488)
2013 (9951)
2012 (10657)
2011 (11230)
2010 (10678)
Location
Africa (277)
Alabama (35)
Alaska (3)
Arizona (104)
Arkansas (1)
Asia (15765)
Australia (2294)
California (5009)
Canada (1817)
China (276)
Colorado (158)
Connecticut (201)
Delaware (156)
Europe (35672)
Florida (628)
Georgia (99)
Hawaii (2)
Idaho (28)
Illinois (259)
India (26)
Indiana (216)
Iowa (11)
Japan (221)
Kansas (41)
Kentucky (21)
Louisiana (11)
Maine (53)
Maryland (502)
Massachusetts (3820)
Michigan (151)
Minnesota (242)
Mississippi (2)
Missouri (48)
Montana (20)
Nebraska (15)
Nevada (58)
New Hampshire (28)
New Jersey (1683)
New Mexico (11)
New York (1211)
North Carolina (628)
North Dakota (6)
Northern California (2487)
Ohio (146)
Oklahoma (11)
Oregon (15)
Pennsylvania (834)
Puerto Rico (6)
Rhode Island (20)
South America (412)
South Carolina (18)
Southern California (1934)
Tennessee (78)
Texas (670)
United States (17361)
Utah (143)
Virginia (104)
Washington D.C. (29)
Washington State (390)
West Virginia (3)
Wisconsin (67)
Wyoming (2)
309,216 Results for "reaction biology corp".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
ARS Pharma Launches Get neffy® on Us for Patients with Severe Allergic Reactions to Improve Access to neffy (epinephrine nasal spray)
November 5, 2025
·
8 min read
Press Releases
Sharp Therapeutics Corp. Reports Third Quarter 2025 Results and Development Update
November 26, 2025
·
3 min read
Press Releases
From reaction to resolution: The future of allergy treatment
July 1, 2025
·
1 min read
Press Releases
Cadwell and Medical Informatics Corp. Announce Partnership to Bring Neurodiagnostic Data into Clinical Intelligence Ecosystem
December 12, 2025
·
3 min read
Press Releases
neffy® (epinephrine nasal spray) Approved in Japan as the First and Only Needle-Free Emergency Treatment of Allergic Reactions (anaphylaxis)
September 22, 2025
·
10 min read
Pharm Country
Reaction Biology Launches Innovative Offering Within Its Kinase Testing Platform and Presents New Data at the American Association for Cancer Research (AACR) Annual Meeting 2024
Reaction Biology (“Reaction” or the “Company”), an industry-leading provider of drug discovery and development services, today announced that it will feature its recently launched HotSpot™ ATP-Max KinomeScreen at the American Association for Cancer Research (AACR) Annual Meeting 2024, held April 7-10, 2024, in San Diego, California.
April 3, 2024
·
6 min read
Press Releases
CYIOS Corp. Appoints John O’Shea as Chief Executive Officer to Lead Next Phase of Growth and Innovation
December 3, 2025
·
5 min read
Press Releases
Phlow Corp. CEO Outlines Path to Pharmaceutical Sovereignty in Testimony Before U.S. Senate
November 21, 2025
·
4 min read
Press Releases
OrthoPediatrics Corp. Reports Third Quarter 2025 Financial Results
October 28, 2025
·
19 min read
Regulatory
FDA Pauses Denali’s Pompe Plans Due to Preclinical Safety Signals
Hypersensitivity reactions in a mouse model prompted the agency to suspend Denali’s planned Phase I development for DNL952 for Pompe disease.
December 5, 2025
·
2 min read
·
Tristan Manalac
1 of 30,922
Next
